The evidence used to demonstrate the transportation and/or storage conditions of each lot or batch of the drug was inadequate. The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate. Investigations into deviations, reports, and/or follow-up actions were inadequate.
Inspection Record
Mediscope Ltd. — Health Canada Inspection Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
The traceability, legibility, documentation, formatting, and/or the accuracy of records was inadequate. Documents were not available on the premises.
The segregation, rotation of stock, and/or the transportation of raw materials, packaging materials, intermediates, bulk drugs, and/or finished products was inadequate.
The written procedures for recalls were inadequate. The computerized system used to manage product inventory and distribution records to support recalls was not validated. The written agreement outlining the respective responsibilities of the importer, distributor, and/or wholesaler for recalls was inadequate.
About this record
Extracted automatically from the document of the Health Canada inspection on 2025-04-04. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
